P

Inventor

SINGH ONKAR N

US16 patents
⚠️ This page may combine multiple inventors who share the name “SINGH ONKAR N”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALCON INC

3 patents
US7001615B1Feb 21, 2006

Sustained release ophthalmic, otic and nasal suspension

ALCON INC122 citations97
US6995186B2Feb 7, 2006

Olopatadine formulations for topical administration

ALCON INC33 citations91
US7402609B2Jul 22, 2008

Olopatadine formulations for topical administration

ALCON INC3 citations61

ALCON UNIVERSAL LTD

3 patents
US6359016B2Mar 19, 2002

Topical suspension formulations containing ciprofloxacin and dexamethasone

ALCON UNIVERSAL LTD48 citations95
US6284804B1Sep 4, 2001

Topical suspension formulations containing ciprofloxacin and dexamethasone

ALCON UNIVERSAL LTD76 citations95
US6462033B2Oct 8, 2002

Process for manufacturing compositions containing ciprofloxacin and hydrocortisone

ALCON UNIVERSAL LTD2 citations62

SINGH ONKAR N

2 patents
US8399508B2Mar 19, 2013

Olopatadine formulations for topical nasal administration

SINGH ONKAR N26 citations90
US8173671B2May 8, 2012

Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate

SINGH ONKAR N2 citations59

ALCON RES LTD

2 patents
US7888370B2Feb 15, 2011

Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate

ALCON RES LTD5 citations72
US9533053B2Jan 3, 2017

High concentration olopatadine ophthalmic composition

ALCON RES LTD0 citations49

INSYS DEV CO INC

2 patents
US9662334B2May 30, 2017

Sildenafil sublingual spray formulations

INSYS DEV CO INC1 citations48
US10111833B2Oct 30, 2018

Sildenafil sublingual spray formulations

INSYS DEV CO INC1 citations45

NOVARTIS AG

1 patent
US7977376B2Jul 12, 2011

Olopatadine formulations for topical nasal administration

NOVARTIS AG28 citations92

ALCON LAB INC

1 patent
US6486208B1Nov 26, 2002

Sustained release, and comfortable opthalmic composition and method for ocular therapy

ALCON LAB INC27 citations90

GAMACHE DANIEL A

1 patent
US8791154B2Jul 29, 2014

High concentration olopatadine ophthalmic composition

GAMACHE DANIEL A28 citations86

EASTERN VIRGINIA MEDICAL SCHOOL

1 patent
US12370203B2Jul 29, 2025

Pharmaceutical compositions and methods of making on demand solid dosage formulations

EASTERN VIRGINIA MEDICAL SCHOOL0 citations50